Beam Therapeutics Inc. (BEAM) Insider Trading Disclosures
Beam Therapeutics Inc. (BEAM) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: BEAM
CIK: 1745999
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte & Touche LLP
Auditor SinceSince 12/31/2018 12:00:00 AM
Lead Engagement PartnerBrian McAllister
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-16 | 2026-10-15 | 4 | 0001193125-26-424421 | View SEC Doc Filr Page |
| 144 | 2026-10-16 | — | 144 Filing | 0001950047-26-010282 | View SEC Doc Filr Page |
| 144 | 2026-10-15 | — | 144 Filing | 0001950047-26-010253 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-10-01 | 4 | 0001193125-26-412236 | View SEC Doc Filr Page |
| 4 | 2026-09-25 | 2026-09-24 | 4 | 0001193125-26-402814 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001104659-26-096939 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-13 | — | SCHEDULE 13G/A Filing | 0000908834-26-000397 | View SEC Doc Filr Page |
| 10-Q | 2026-08-04 | 2026-06-30 | 10-Q | 0001193125-26-331541 | View SEC Doc Filr Page |
| 8-K | 2026-08-04 | 2026-08-04 | 8-K | 0001193125-26-331522 | View SEC Doc Filr Page |
| 4 | 2026-07-29 | 2026-07-27 | 4 | 0001193125-26-323640 | View SEC Doc Filr Page |
| 144 | 2026-07-27 | — | 144 Filing | 0001950047-26-007314 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-06-30 | 4 | 0001193125-26-294478 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-06-29 | 4 | 0001193125-26-292526 | View SEC Doc Filr Page |
| 144 | 2026-06-30 | — | 144 Filing | 0001950047-26-006639 | View SEC Doc Filr Page |
| 144 | 2026-06-29 | — | 144 Filing | 0001950047-26-006578 | View SEC Doc Filr Page |
| 4 | 2026-06-29 | 2026-06-25 | 4 | 0001193125-26-288078 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-17 | 4 | 0001193125-26-277509 | View SEC Doc Filr Page |
| 8-K | 2026-06-08 | 2026-06-03 | 8-K | 0001193125-26-261693 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-03 | 4 | 0001193125-26-259529 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-03 | 4 | 0001193125-26-259526 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-03 | 4 | 0001193125-26-259524 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-03 | 4 | 0001193125-26-259536 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-03 | 4 | 0001193125-26-259534 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-03 | 4 | 0001193125-26-259519 | View SEC Doc Filr Page |
| 10-Q | 2026-05-07 | 2026-03-31 | 10-Q | 0001193125-26-210338 | View SEC Doc Filr Page |